Revision history of "Identification of epigenetic obesity biomarkers indicative of susceptibility to different treatments and re-gaining of body weight" (Q3138273)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 March 2024

20 December 2023

12 June 2023

10 June 2023

17 August 2022

  • curprev 19:3019:30, 17 August 2022DG Regio talk contribs 68,932 bytes +46,960 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

2 December 2021

  • curprev 11:1211:12, 2 December 2021DG Regio talk contribs 14,670 bytes +2,308 Created claim: summary (P836): L’obésité est définie comme une accumulation excessive ou pathologique de graisse, mais son diagnostic est basé sur la valeur de l’indice de masse corporelle (IMC) qui ne tient pas toujours compte de la quantité de masse grasse, de sa proportion à la masse musculaire ou de son emplacement anatomique. Par conséquent, il y a un besoin clinique d’utiliser des marqueurs biochimiques objectifs et fiables liés à l’adipositie viscérale qui sont révélat...
  • curprev 11:1211:12, 2 December 2021DG Regio talk contribs 12,362 bytes +216 Changed label, description and/or aliases in fr: translated_label

12 October 2021

  • curprev 12:3312:33, 12 October 2021DG Regio talk contribs 12,146 bytes +190 Changed label, description and/or aliases in en: translated_label
  • curprev 12:3312:33, 12 October 2021DG Regio talk contribs 11,956 bytes +2,058 Created claim: summary (P836): Obesity is defined as an excessive or pathological accumulation of fat, but its diagnosis is based on the value of the body mass index (BMI) which does not always take into account the amount of fat mass, its proportion to muscle mass or its anatomical location. Therefore, there is a clinical need to use objective, reliable biochemical markers related to visceral adiposity that are indicative of a danger to the patient. In addition, these biomar...

10 October 2021

9 October 2021

7 October 2021